Literature DB >> 9207343

JC virus (JCV) genotypes in brain tissue from patients with progressive multifocal leukoencephalopathy (PML) and in urine from controls without PML: increased frequency of JCV type 2 in PML.

H T Agostini1, C F Ryschkewitsch, R Mory, E J Singer, G L Stoner.   

Abstract

Progressive multifocal leukoencephalopathy (PML) is caused by the human polyomavirus JC (JCV), and there are at least 4 different genotypes of JCV in the United States. Type 1 strains are of European origin, whereas type 2 and 3 strains are of Asian and African origin, respectively. JCV type 4 strains are derived from a type 1/3 recombinant. In this study, the genotype distribution of JCV strains found in brain tissue or cerebrospinal fluid of 50 PML patients was compared with JCV genotypes excreted in the urine of 103 control subjects. Type determination was based on the polymerase chain reaction-amplified partial sequence of the VP1 coding gene and the noncoding region left of ori. Brain tissues from patients with PML were infected with a significantly higher proportion of JCV type 2 strains than were urine samples from the control group (P = .004). This evidence indicates a biologic difference between JCV genotypes and suggests a difference in their potential to cause PML.

Entities:  

Mesh:

Year:  1997        PMID: 9207343     DOI: 10.1086/514010

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  26 in total

Review 1.  Methods for subtyping and molecular comparison of human viral genomes.

Authors:  M Arens
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

2.  Increased frequency of JC virus type 2 and of dual infection with JC virus type 1 and 2 in Italian progressive multifocal leukoencephalopathy patients.

Authors:  P Ferrante; M Mediati; R Caldarelli-Stefano; L Losciale; R Mancuso; A E Cagni; R Maserati
Journal:  J Neurovirol       Date:  2001-02       Impact factor: 2.643

3.  Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MS.

Authors:  J Kuhle; R Gosert; R Bühler; T Derfuss; R Sutter; O Yaldizli; E-W Radue; C Ryschkewitsch; E O Major; L Kappos; S Frank; H H Hirsch
Journal:  Neurology       Date:  2011-11-09       Impact factor: 9.910

4.  Dual qualitative-quantitative nested PCR for detection of JC virus in cerebrospinal fluid: high potential for evaluation and monitoring of progressive multifocal leukoencephalopathy in AIDS patients receiving highly active antiretroviral therapy.

Authors:  D García de Viedma; R Alonso; P Miralles; J Berenguer; M Rodriguez-Créixems; E Bouza
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

5.  Detectable cerebrospinal fluid JCV DNA in late-presenting HIV-positive patients: beyond progressive multifocal leukoencephalopathy?

Authors:  S Mornese Pinna; E Scarvaglieri; M G Milia; D Imperiale; V Ghisetti; S Audagnotto; A Prochet; F Lipani; S Bonora; G Di Perri; A Calcagno
Journal:  J Neurovirol       Date:  2017-07-05       Impact factor: 2.643

Review 6.  Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies.

Authors:  Eric M L Williamson; Joseph R Berger
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 7.  Persistence and pathogenesis of the neurotropic polyomavirus JC.

Authors:  Hassen S Wollebo; Martyn K White; Jennifer Gordon; Joseph R Berger; Kamel Khalili
Journal:  Ann Neurol       Date:  2015-03-06       Impact factor: 10.422

8.  Tubulointerstitial nephritis due to a mutant polyomavirus BK virus strain, BKV(Cin), causing end-stage renal disease.

Authors:  R D Smith; J H Galla; K Skahan; P Anderson; C C Linnemann; G S Ault; C F Ryschkewitsch; G L Stoner
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

9.  Propagation of archetype and nonarchetype JC virus variants in human fetal brain cultures: demonstration of interference activity by archetype JC virus.

Authors:  Frank J O'Neill; John E Greenlee; Kristina Dörries; Susan A Clawson; Helen Carney
Journal:  J Neurovirol       Date:  2003-10       Impact factor: 2.643

10.  Molecular analysis of JC virus genotypes circulating among the Italian healthy population.

Authors:  Elisabetta Pagani; Serena Delbue; Roberta Mancuso; Elisa Borghi; Letizia Tarantini; Pasquale Ferrante
Journal:  J Neurovirol       Date:  2003-10       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.